Ara
Toplam kayıt 52, listelenen: 41-50
What else could be done for management of cancer patients in ED? Challenges and suggestions (cancer patients and emergency service)
(W B Saunders Co-Elsevier Inc, 2015)
Fibromyalgia and breast cancer
(Springer Japan Kk, 2014)
The Perspective of Non-oncologist Physicians on Patients with Metastatic Cancer and Palliative Care (ALONE Study): A Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)
(Springer, 2015)
The aim of our study was to determine the perspective of non-oncologist physicians regarding their attitudes and beliefs associated with palliative care for patients with metastatic cancer. The study was planned as a ...
Acute Effect on QT Dispersion and Cardiac Function of Trastuzumab: A Controversial Situation
(Sage Publications Inc, 2016)
Is a new perspective for definition and diagnostic criteria of fibromyalgia in early stage cancer patients necessary?
(Churchill Livingstone, 2014)
Fibromyalgia is a most common pain syndrome characterized by the presence of chronic widespread pain and tenderness with manual palpation. However there is no enough data about frequent of fibromyalgia syndrome in patients ...
Is there any effect of bolus and/or infusion 5-fluorouracil treatment on microalbuminuria in immediate or long term?
(Churchill Livingstone, 2014)
5-Fluorouracil is a widely used cytotoxic chemotherapeutic agent in the treatment settings particularly in patients with gastrointestinal cancer. Various studies on the cardiac adverse effects of 5-fluorouracil, reported ...
Being a medical oncologist during the COVID-19 pandemic: Perception, expectations and concerns. OATH study
(Elsevier, 2021)
In COVID-19 pandemic, medical oncologists worked actively both in their own fields and in COVID-19 health services.
Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study
(CINVD, 2021)
Purpose: This study evaluated the efficacy and safety of everolimus (EVE) plus exemestane (EXE) in hormone-receptor positive (HR+), human epidermal growth factor receptor-2-negative (HER2−) metastatic breast cancer (MBC) ...